1-3 of 3
Keywords: Advanced melanoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy

Open Access
Subject Area:
Oncology
Yumi Kambayashi, Taku Fujimura, Hiroshi Kuroda, Atsushi Otsuka, Hiroyuki Irie, Setsuya Aiba
Journal: Case Reports in Oncology
Case Rep Oncol (2020) 13 (1): 474–477.
https://doi.org/10.1159/000506976
Published Online: 30 April 2020
...) analysis, which revealed that this patient possessed HLA-DQB1 polymorphisms (DQB1*040101 and *060401). In this report, we have described a case of immune-related demyelinating peripheral neuropathy with cranial neuropathy caused by N + I combined therapy for advanced melanoma, successfully treated...
View article titled, Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy
Open the PDF for Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy in another window
Journal Articles

Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy

Open Access
Subject Area:
Oncology
Saaya Yoshida, Taku Fujimura, Yumi Kambayashi, Ryo Amagai, Akira Hashimoto, Setsuya Aiba
Journal: Case Reports in Oncology
Case Rep Oncol (2020) 12 (3): 829–833.
https://doi.org/10.1159/000504019
Published Online: 30 October 2019
...Saaya Yoshida; Taku Fujimura; Yumi Kambayashi; Ryo Amagai; Akira Hashimoto; Setsuya Aiba Nivolumab plus ipilimumab combined therapy is one of the promising drugs that enhance the anti- immune response in patients with advanced melanoma. Therefore, to increase its response rate is of great interest...
View article titled, Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy
Open the PDF for Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy in another window
Journal Articles

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab

Open Access
Subject Area:
Oncology
Kayo Tanita, Taku Fujimura, Yumi Kambayashi, Akira Tsukada, Yota Sato, Akira Hashimoto, Setsuya Aiba
Journal: Case Reports in Oncology
Case Rep Oncol (2018) 11 (1): 114–118.
https://doi.org/10.1159/000487127
Published Online: 15 February 2018
...Kayo Tanita; Taku Fujimura; Yumi Kambayashi; Akira Tsukada; Yota Sato; Akira Hashimoto; Setsuya Aiba Since the efficacy of ipilimumab on nivolumab-resistant advanced melanoma is extremely low, additional supportive therapy for anti-PD-1 antibody therapy-resistant advanced melanoma is needed...
View article titled, Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab
Open the PDF for Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab in another window